AstraZeneca says 'no evidence' of blood clot risk from vaccine as countries suspend its use
CNN
The global rollout of the Oxford-AstraZeneca Covid-19 vaccine encountered another hurdle after a handful of countries paused their use of the shot, awaiting more information following reports the vaccine could be linked to blood clots, despite no clear evidence of a link.
AstraZeneca has robustly defended its vaccine, saying Friday there was "no evidence of an increased risk" of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed and that rollouts should continue. After a group of European countries -- including Denmark, Norway and Iceland -- suspended use of the vaccine on Thursday, Thailand's Prime Minister, Prayut Chan-o-cha, canceled plans to publicly get the AstraZeneca shot on Friday and the country also delayed its rollout.More Related News